CIK 0001853816
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | HALE DAVID F Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2025-01-23 | HALE DAVID F Director | Grant or award | +78,741 | 80,957 | ||
| 2025-01-21 | HALE DAVID F Director | Grant or award · Warrant (Right to Buy) | +78,741 | 78,741 | ||
| 2025-01-13 | HALE DAVID F Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-01-04 | HALE DAVID F Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-10-06 | HALE DAVID F Director | Grant or award | +30,155 | 75,720 | ||
| 2022-07-07 | HALE DAVID F Director | Grant or award | +26,441 | 45,565 | ||
| 2022-04-07 | HALE DAVID F Director | Grant or award | +15,466 | 19,124 | ||
| 2022-01-03 | HALE DAVID F Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion | +44,777 | 299,411 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion | +12,195 | 311,606 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion | +20,000 | 331,606 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion | +174,216 | 505,822 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion | +27,103 | 532,925 | ||
| 2021-08-17 | HALE DAVID F Director | Purchase | +35,714 | 35,714 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion · Series 1d Preferred Stock | −302,112 | 0 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion · Series 1a Preferred Stock | −250,000 | 0 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion · Series 1b Preferred Stock | −410,000 | 0 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion · Series 1c Preferred Stock | −3,571,428 | 0 | ||
| 2021-08-17 | HALE DAVID F Director | Conversion · Series 1 Preferred Stock | −555,622 | 0 |
Page 1 of 2 · 23 trades